Protection of clinical trial subjects in countries outside the EU
Posted in category:
Publication
Published on:
In this briefing paper, Wemos and SOMO call upon the European Parliament, the European Commission and the European Medicines Agency to take measures at the following three levels: 1) Vigorously pursue the integration of ethical principles into EMA procedures, 2) Increase transparency in clinical trials outside the EU and 3) Strengthen capacity in low and middle income countries.
Do you need more information?
-
Irene Schipper
Senior Researcher
Partners
Publication
Related news
-
-
Big Pharma raked in USD 90 billion in profits with COVID-19 vaccinesPosted in category:News
Esther de HaanPublished on: -
Pharma’s pandemic profits Published on:
Esther de HaanPosted in category:Publication
Esther de Haan
